Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller-Tidow

Showing results (1-10 of 532) with videos related to

Pageof 54
Sort By:
Cancer Treatment Reviews|May 27, 2011
DNA methylation as a pathogenic event and as a therapeutic target in AMLTill Schoofs, Carsten Müller-Tidow
Molecular & Cellular Oncology|April 13, 2017
Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemiaStefanie Göllner, Carsten Müller-Tidow
Molecular Therapy. Methods & Clinical Development|March 4, 2024
Genome editing in clinical practice: A model study for next-gen hematopoietic cell transplants in hematologic malignanciesPatrick Derigs, Carsten Müller-Tidow
Nature Cancer|July 26, 2022
AKTing on XPO1 inhibition in AMLStefanie Göllner, Carsten Müller-Tidow
Blood|May 22, 2025
Inflammation conjoins differentiation and resistance in AMLMaike Janssen, Carsten Müller-Tidow
Nature Genetics|October 2, 2019
NPM1 functions in epitranscriptomicsFengbiao Zhou, Carsten Müller-Tidow
Reproductive Biomedicine Online|December 10, 2002
Genes associated with the development of the male germ lineCarol Readhead, Carsten Müller-Tidow
Nature Cell Biology|February 20, 2019
IRE1α maintains HSC stemness under ER-stressMarina Scheller-Wendorff, Carsten Müller-Tidow
Cancer Treatment Reviews|May 27, 2011
Mechanism of action of demethylating and immune modulatory agents--conclusionCarsten Müller-Tidow, Wolf-K Hofmann
The Lancet. Oncology|January 18, 2018
A new option for remission induction in acute myeloid leukaemiaCarsten Müller-Tidow, Richard F Schlenk
Pageof 54

Showing results (1-10 of 532) with videos related to

Sort By:
Pageof 54
Cancer Treatment Reviews|May 27, 2011
DNA methylation as a pathogenic event and as a therapeutic target in AMLTill Schoofs, Carsten Müller-Tidow
Molecular & Cellular Oncology|April 13, 2017
Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemiaStefanie Göllner, Carsten Müller-Tidow
Molecular Therapy. Methods & Clinical Development|March 4, 2024
Genome editing in clinical practice: A model study for next-gen hematopoietic cell transplants in hematologic malignanciesPatrick Derigs, Carsten Müller-Tidow
Nature Cancer|July 26, 2022
AKTing on XPO1 inhibition in AMLStefanie Göllner, Carsten Müller-Tidow
Blood|May 22, 2025
Inflammation conjoins differentiation and resistance in AMLMaike Janssen, Carsten Müller-Tidow
Nature Genetics|October 2, 2019
NPM1 functions in epitranscriptomicsFengbiao Zhou, Carsten Müller-Tidow
Reproductive Biomedicine Online|December 10, 2002
Genes associated with the development of the male germ lineCarol Readhead, Carsten Müller-Tidow
Nature Cell Biology|February 20, 2019
IRE1α maintains HSC stemness under ER-stressMarina Scheller-Wendorff, Carsten Müller-Tidow
Cancer Treatment Reviews|May 27, 2011
Mechanism of action of demethylating and immune modulatory agents--conclusionCarsten Müller-Tidow, Wolf-K Hofmann
The Lancet. Oncology|January 18, 2018
A new option for remission induction in acute myeloid leukaemiaCarsten Müller-Tidow, Richard F Schlenk
Pageof 54